Accelerating Global Access to Gene Therapies: Case Studies from Low- and Middle-Income Countries
This report provides case studies of gene therapies in low- and middle-income countries (LMICs) in an effort to accelerate global access to these treatments. The report highlights the potential of gene therapies to address unmet medical needs in LMICs, as well as the challenges that must be overcome to ensure equitable access to these treatments.
The report begins with an introduction to the case for gene therapies in LMICs, including the potential to address unmet medical needs and the importance of ensuring equitable access to these treatments. The report then provides a landscape of gene therapies, including the rise of these treatments and expectations for innovation and the economy. The report also highlights the widening global gap in access to gene therapies.
The report then delves into the capacity pillars for gene therapies in LMICs, including research and development, health facilities, manufacturing, workforce, community engagement, and policy and regulation. The report also includes case studies of gene therapies in Uganda, Tanzania, South Africa, Thailand, and India.
The report concludes with questions about the future of gene therapies in LMICs and the importance of collaboration and cooperation to ensure equitable access to these treatments. The report also includes a list of contributors and endnotes.
Overall, this report provides valuable insights into the potential of gene therapies to address unmet medical needs in LMICs and the challenges that must be overcome to ensure equitable access to these treatments.
